DURECT Corp
NASDAQ:DRRX

Watchlist Manager

DURECT Corp

NASDAQ:DRRX

Watchlist

Dividends

Price: 1.26 USD -2.33% Market Closed

Market Cap: 39.1m USD

Have any thoughts about
DURECT Corp?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 1.26 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

DRRX Alert

DURECT Corp

1.26

-0.03 (-2.33%)

52 Week Range	0.5 2.98
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

DURECT Corp

What unique competitive advantages
does DURECT Corp hold over its rivals?

What risks and challenges
does DURECT Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of DURECT Corp.

What unique competitive advantages
does DURECT Corp hold over its rivals?

What risks and challenges
does DURECT Corp face in the near future?

Has there been any significant insider trading activity
in DURECT Corp recently?

Summarize the latest earnings call
of DURECT Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for DURECT Corp.

Provide P/S
for DURECT Corp.

Provide P/E
for DURECT Corp.

Provide P/OCF
for DURECT Corp.

Provide P/FCFE
for DURECT Corp.

Provide P/B
for DURECT Corp.

Provide EV/S
for DURECT Corp.

Provide EV/GP
for DURECT Corp.

Provide EV/EBITDA
for DURECT Corp.

Provide EV/EBIT
for DURECT Corp.

Provide EV/OCF
for DURECT Corp.

Provide EV/FCFF
for DURECT Corp.

Provide EV/IC
for DURECT Corp.

Show me price targets
for DURECT Corp made by professional analysts.

What are the Revenue projections
for DURECT Corp?

How accurate were the past Revenue estimates
for DURECT Corp?

What are the Net Income projections
for DURECT Corp?

How accurate were the past Net Income estimates
for DURECT Corp?

What are the EPS projections
for DURECT Corp?

How accurate were the past EPS estimates
for DURECT Corp?

What are the EBIT projections
for DURECT Corp?

How accurate were the past EBIT estimates
for DURECT Corp?

Compare the revenue forecasts
for DURECT Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of DURECT Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of DURECT Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of DURECT Corp compared to its peers.

Compare the P/E ratios
of DURECT Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing DURECT Corp with its peers.

Analyze the financial leverage
of DURECT Corp compared to its main competitors.

Show all profitability ratios
for DURECT Corp.

Provide ROE
for DURECT Corp.

Provide ROA
for DURECT Corp.

Provide ROIC
for DURECT Corp.

Provide ROCE
for DURECT Corp.

Provide Gross Margin
for DURECT Corp.

Provide Operating Margin
for DURECT Corp.

Provide Net Margin
for DURECT Corp.

Provide FCF Margin
for DURECT Corp.

Show all solvency ratios
for DURECT Corp.

Provide D/E Ratio
for DURECT Corp.

Provide D/A Ratio
for DURECT Corp.

Provide Interest Coverage Ratio
for DURECT Corp.

Provide Altman Z-Score Ratio
for DURECT Corp.

Provide Quick Ratio
for DURECT Corp.

Provide Current Ratio
for DURECT Corp.

Provide Cash Ratio
for DURECT Corp.

What is the historical Revenue growth
over the last 5 years for DURECT Corp?

What is the historical Net Income growth
over the last 5 years for DURECT Corp?

What is the current Free Cash Flow
of DURECT Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for DURECT Corp.

EV/EBITDA
Enterprise Value to EBITDA

-0.9

Current

-1.9

Median

13.6

Industry

Higher than median

Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

-0.9

Enterprise Value

23.5m USD

EBITDA

-24.9m USD

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
US		DURECT Corp NASDAQ:DRRX	39.1m USD	-0.9
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	776 550.9T JPY	-5 459 134.4
US		Eli Lilly and Co NYSE:LLY	871.6B USD	59.3
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	3 846.3
DK		Novo Nordisk A/S CSE:NOVO B	3.6T DKK	26.7
US		Johnson & Johnson NYSE:JNJ	395.9B USD	13
US		Merck & Co Inc NYSE:MRK	278.3B USD	13.7
CH		Roche Holding AG SIX:ROG	216.5B CHF	10.6
UK	A	AstraZeneca PLC NASDAQ:AZN	241.9B USD	17.2
CH		Novartis AG SIX:NOVN	197.5B CHF	11.1
US		Pfizer Inc NYSE:PFE	165.9B USD	12.8

				EBITDA Growth
US		DURECT Corp NASDAQ:DRRX	Average EV/EBITDA: 445.6 Negative Multiple: -0.9	N/A
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Negative Multiple: -5 459 134.4	N/A
US		Eli Lilly and Co NYSE:LLY	59.3	191%
UK		Dechra Pharmaceuticals PLC LSE:DPH	3 846.3	151%
DK		Novo Nordisk A/S CSE:NOVO B	26.7	86%
US		Johnson & Johnson NYSE:JNJ	13	12%
US		Merck & Co Inc NYSE:MRK	13.7	342%
CH		Roche Holding AG SIX:ROG	10.6	21%
UK	A	AstraZeneca PLC NASDAQ:AZN	17.2	60%
CH		Novartis AG SIX:NOVN	11.1	9%
US		Pfizer Inc NYSE:PFE	12.8	30%

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

-0.7

2-Years Forward

EV/EBITDA

-0.6

3-Years Forward

EV/EBITDA

N/A

DURECT Corp
NASDAQ:DRRX

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

DURECT Corp NASDAQ:DRRX

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

DURECT Corp
NASDAQ:DRRX

EV/EBITDA
Enterprise Value to EBITDA